Your browser doesn't support javascript.
loading
Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
Johnson, Matthew; Morrison, Fritha J; McMahon, Gearoid; Su, Maxwell; Turchin, Alexander.
Afiliación
  • Johnson M; Division of Endocrinology, Brigham and Women's Hospital, Boston, MA; Columbia University College of Physicians and Surgeons, New York, NY.
  • Morrison FJ; Division of Endocrinology, Brigham and Women's Hospital, Boston, MA.
  • McMahon G; Division of Endocrinology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
  • Su M; Harvard School of Public Health, Boston, MA; Phase V, Wellesley Hills, MA.
  • Turchin A; Division of Endocrinology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: aturchin@bwh.harvard.edu.
Am Heart J ; 258: 49-59, 2023 04.
Article en En | MEDLINE | ID: mdl-36642227

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Insuficiencia Renal Crónica / Insuficiencia Cardíaca / Hiperpotasemia Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Am Heart J Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Insuficiencia Renal Crónica / Insuficiencia Cardíaca / Hiperpotasemia Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Am Heart J Año: 2023 Tipo del documento: Article